HighTower Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,650
| Closed | -$20K | – | 3108 |
|
|
2022
Q2 | $20K | Buy |
+16,650
| New | +$20K | ﹤0.01% | 2925 |
|
|
2020
Q4 | – | Sell |
-35,293
| Closed | -$117K | – | 2689 |
|
|
2020
Q3 | $117K | Sell |
35,293
-6,300
| -15% | -$20.9K | ﹤0.01% | 2178 |
|
|
2020
Q2 | $141K | Hold |
41,593
| – | – | ﹤0.01% | 2038 |
|
|
2020
Q1 | $159K | Sell |
41,593
-2,250
| -5% | -$8.6K | ﹤0.01% | 1828 |
|
|
2019
Q4 | $265K | Sell |
43,843
-25
| -0.1% | -$151 | ﹤0.01% | 1786 |
|
|
2019
Q3 | $333K | Sell |
43,868
-20,125
| -31% | -$153K | ﹤0.01% | 1719 |
|
|
2019
Q2 | $867K | Sell |
63,993
-31,500
| -33% | -$427K | 0.01% | 1253 |
|
|
2019
Q1 | $518K | Buy |
95,493
+11,000
| +13% | +$59.7K | ﹤0.01% | 1445 |
|
|
2018
Q4 | $251K | Sell |
84,493
-7,250
| -8% | -$21.5K | ﹤0.01% | 1702 |
|
|
2018
Q3 | $748K | Buy |
91,743
+8,350
| +10% | +$68.1K | 0.01% | 1263 |
|
|
2018
Q2 | $812K | Hold |
83,393
| – | – | 0.01% | 1226 |
|
|
2018
Q1 | $725K | Hold |
83,393
| – | – | 0.01% | 1250 |
|
|
2017
Q4 | $1.05M | Buy |
+83,393
| New | +$1.05M | 0.01% | 1084 |
|